American Business Daily: Roche targets DNA sequencing technology in $350 million deal for Genia

If you are having trouble viewing this email, click here

June 2, 2014

NEWS FROM AROUND THE COUNTRY Roche targets DNA sequencing technology in $350 million deal for Genia EPA set to release new power plant emissions standards Lewis Katz, Philadelphia Inquirer owner, dead in plane crash L.A. sues JPMorgan Chase over minority loans Shinseki out at VA, but Obama cites 'distraction,' not management failure Try our Newsstand App for 4 weeks FREE. Select from 40 business journals and get the Weekly Edition on your iPad or iPhone. Next>> Google balloon falls from the sky in central Washington Jessica Alba to sell her Honest products at Target George R.R. Martin finds taste of Westeros in Charlotte It wasn't just Edward Snowden: Cyber breaches reported by federal agencies spiked in 2013 What's the best ride? We compare Boeing and SpaceX capsules for NASA Apple-Beats: Assessing how long the honeymoon will last FTC okays Furiex Pharmaceuticals' $1.46B acquisition by Forest Laboratories International Paper CEO Faraci set to retire Peyton Manning, Denver Broncos sign twin marketing deals with Nationwide Insurance Lowe's CEO still wants the company to grow -- but not too quickly What Google's diversity numbers tell us, and what every company can do to improve Foursquare loses two key execs Will Facebook be your next bank? 5 ways Elon Musk's Dragon V2 rocks our universe New bill would limit FCC from classifying broadband carriers as utility Glamping: 5 camping resorts where the tent is already pitched for you Amazon Prime music streaming service reportedly coming this summer How to design office spaces to attract and retain great talent

COMPANIES IN THE NEWS Genentech Illumina Thermo Fisher Scientific Columbia University Harvard University Roche Environmental Protection Agency Clorox Philadelphia Inquirer Philadelphia Daily News New Jersey Nets New Jersey Devils Central Parking Orleans Homebuilders Wells Fargo& TOPICS IN THE NEWS Biotech Pharmaceuticals Innovation Mergers and Acquisitions Health Care Environment Banking & Financial Services Energy Investing Entertainment

Cancel Email Subscription You may change your email address, your preferences, or unsubscribe from this email at any time by visiting bizjournals.com: https://www.bizjournals.com/account/bizjournals If you need other assistance, please let us know or contact: bizjournals.com customer service, bizjournals 120 W. Morehead St., Charlotte, North Carolina 28202 © 2014 American City Business Journals, Inc. and its licensors. All rights reserved. The material on this may not be reproduced, distributed, transmitted, cached or otherwise used, except with the written permission of bizjournals.